Trial intelligence / Profile preview

Ginkgo biloba extract for cisplatin-induced ototoxicity

NCT01139281Phase 2Completed

Sponsor
University of Brasília
Start
Jun 2007
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ginkgo biloba extract in ototoxicity, hearing loss, sponsored by University of Brasília. Started Jun 2007; status: completed.

02

Drugs

ginkgo biloba extract
03

Conditions

ototoxicityhearing loss

Beyond the preview

Go deeper on NCT01139281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01139281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call